Literature DB >> 6601655

Cefotetan and beta-lactamases. II. An unusual property: the inactivation of some beta-lactamases by cefotetan.

R Labia, A Morand, J Peduzzi.   

Abstract

Initially, cefotetan interacts with beta-lactamases to form a classical Michaelis complex characterized by a term Ki (the inhibition constant). In a second phase, this complex develops with time to form a new entity devoid of enzymic activity. This new entity may have the structure of an acyl enzyme with variable stability. In the case of TEM-1 and TEM-2 beta-lactamases, the process is progressively and totally reversible. The same phenomena were observed in varying degrees for Pitton's type 2 (PIT-2) penicillinase, OXA-1 and CARB-1. The Klebsiella oxytoca and Proteus vulgaris beta-lactamases are also inactivated by this same process. However, four other cephalosporinases appear to be unaffected by this mechanism.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6601655     DOI: 10.1093/jac/11.suppl_a.153

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  2 in total

Review 1.  Cefotetan. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  A Ward; D M Richards
Journal:  Drugs       Date:  1985-11       Impact factor: 9.546

2.  The Molecular Basis of β-Lactamase Catalysis and Inhibition.

Authors:  A L Fink
Journal:  Pharm Res       Date:  1985-03       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.